Study of purified umbilical cord blood CD34+ stem cell on chronic ischaemic stroke
Overview:
This study is being conducted by researchers at the China Medical
University Hospital in Taiwan. The purpose of the study is to
determine the safety and effectiveness of brain transplants of CD34+
stem cells obtained from umbilical cord blood. The aim is to recruit
participants between 35 years to 70 years of age who have had an
ischaemic stroke more than 6 months and less than 60 months ago.
Participants will receive umbilical cord blood stem cells injected
into the brain around the site damaged by stroke, in combination
with antiplatelet medication and rehabilitation. The donor
(allogeneic) cord blood units will be obtained from cord blood banks
in USA and Taiwan and will be closely HLA ‘matched’ to the
recipient. The study start date was January 2013.
Location: Taichung, Taiwan
Trial design: Safety and efficacy
Status: Not yet recruiting
Find out more